Astrana Health, Inc. (NASDAQ:ASTH) Holdings Raised by Diamond Hill Capital Management Inc.

Diamond Hill Capital Management Inc. grew its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 11.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 159,211 shares of the company's stock after buying an additional 16,911 shares during the quarter. Diamond Hill Capital Management Inc. owned 0.28% of Astrana Health worth $5,020,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Handelsbanken Fonder AB boosted its stake in shares of Astrana Health by 4.7% during the 4th quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company's stock valued at $281,000 after buying an additional 400 shares during the last quarter. Swiss National Bank lifted its stake in Astrana Health by 1.1% during the fourth quarter. Swiss National Bank now owns 88,444 shares of the company's stock worth $2,789,000 after purchasing an additional 1,000 shares during the last quarter. KBC Group NV bought a new position in Astrana Health during the third quarter worth $70,000. Quarry LP bought a new position in Astrana Health during the third quarter worth $77,000. Finally, Moran Wealth Management LLC lifted its stake in Astrana Health by 21.5% during the fourth quarter. Moran Wealth Management LLC now owns 7,944 shares of the company's stock worth $250,000 after purchasing an additional 1,404 shares during the last quarter. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Astrana Health Stock Performance

ASTH stock traded down $0.52 during mid-day trading on Wednesday, reaching $31.51. The company had a trading volume of 397,142 shares, compared to its average volume of 251,303. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The stock has a market capitalization of $1.77 billion, a P/E ratio of 24.24, a P/E/G ratio of 1.37 and a beta of 1.30. Astrana Health, Inc. has a one year low of $23.12 and a one year high of $63.20. The stock's 50-day simple moving average is $33.97 and its two-hundred day simple moving average is $42.83.

Remove Ads

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The company had revenue of $665.21 million for the quarter, compared to the consensus estimate of $617.24 million. Research analysts anticipate that Astrana Health, Inc. will post 1.15 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on ASTH. Bank of America reduced their price objective on Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a research note on Tuesday, March 4th. Macquarie upgraded Astrana Health to a "hold" rating in a research note on Monday, December 16th. Stifel Nicolaus reduced their price objective on Astrana Health from $70.00 to $56.00 and set a "buy" rating on the stock in a research note on Thursday, February 20th. Robert W. Baird reduced their price objective on Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a research note on Monday, March 3rd. Finally, Truist Financial reduced their price objective on Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a research note on Tuesday. Two equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $56.17.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.